Kunzeng Zheng

Title: Kunzeng Zheng: Innovator in Macrocyclic Compounds

Introduction

Kunzeng Zheng is a notable inventor based in Shanghai, China. He has made significant contributions to the field of chemistry, particularly in the development of macrocyclic compounds. With a total of 2 patents, his work focuses on innovative solutions for treating various medical disorders.

Latest Patents

Zheng's latest patents include novel macrocyclic sulfondiimine compounds. These compounds are described by a general formula and are aimed at treating and preventing hyper-proliferative disorders, virally induced infectious diseases, and cardiovascular diseases. Additionally, he has developed macrocyclic compounds that share similar applications and methods for their preparation. Both inventions also include intermediate compounds that are useful in the synthesis of these novel compounds.

Career Highlights

Kunzeng Zheng is currently associated with Bayer Pharma Aktiengesellschaft, a leading global pharmaceutical company. His work at Bayer has allowed him to focus on innovative research and development in the pharmaceutical sector. His contributions have been instrumental in advancing the understanding and treatment of complex medical conditions.

Collaborations

Zheng has collaborated with esteemed colleagues such as Ulrich Lücking and Arne Scholz. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Kunzeng Zheng's innovative work in macrocyclic compounds positions him as a key figure in the pharmaceutical industry. His patents reflect a commitment to addressing significant health challenges through scientific advancement.